Literature DB >> 3028990

Immunocytochemical localization of sphingolipid activator protein-1, the sulfatide/GM1 ganglioside activator, to lysosomes in human liver and colon.

T Tamaru, S Fujibayashi, W R Brown, D A Wenger.   

Abstract

Sphingolipid activator proteins (SAP) stimulate the enzymatic hydrolysis of sphingolipids. The results of biochemical studies have suggested that SAP are located within lysosomes. In this study we sought immunocytochemical verification of the lysosomal location of SAP-1, a SAP that stimulates the hydrolysis of sulfatide and GM1 ganglioside. We stained adjacent sections of normal adult liver and colon for either SAP-1, by peroxidase-labeled antibodies, or acid phosphatase, by enzyme histochemistry. At the light microscopic level, SAP-1 and acid phosphatase were present in similar cells of the colonic lamina propria and hepatic sinusoids, and in similar supranuclear sites of colonic epithelial cells. By electron microscopy, SAP-1 was present in vesicular structures morphologically similar to those containing acid phosphatase. Thus, SAP-1 is present in lysosomes of several different kinds of cells in the normal human liver and colon.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3028990     DOI: 10.1007/BF00493387

Source DB:  PubMed          Journal:  Histochemistry        ISSN: 0301-5564


  15 in total

1.  Peroxidase-labeled antibody. A new method of conjugation.

Authors:  P K Nakane; A Kawaoi
Journal:  J Histochem Cytochem       Date:  1974-12       Impact factor: 2.479

2.  Requirement of an activator for the hydrolysis of sphingoglycolipids by glycosidases of human liver.

Authors:  S C Li; C C Wan; M Y Mazzotta; Y T Li
Journal:  Carbohydr Res       Date:  1974-05       Impact factor: 2.104

3.  Gaucher's disease: deficiency of 'acid' -glucosidase and reconstitution of enzyme activity in vitro.

Authors:  M W Ho; J S O'Brien
Journal:  Proc Natl Acad Sci U S A       Date:  1971-11       Impact factor: 11.205

4.  [A cerebrosidesulfatase from swine kidney].

Authors:  E Mehl; H Jatzkewitz
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1964

5.  Characterization of an activating factor required for hydrolysis of Gm2 ganglioside catalyzed by hexosaminidase A.

Authors:  P Hechtman
Journal:  Can J Biochem       Date:  1977-04

6.  AB variant of infantile GM2 gangliosidosis: deficiency of a factor necessary for stimulation of hexosaminidase A-catalyzed degradation of ganglioside GM2 and glycolipid GA2.

Authors:  E Conzelmann; K Sandhoff
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

7.  Molecular cloning of the sphingolipid activator protein-1 (SAP-1), the sulfatide sulfatase activator.

Authors:  N Dewji; D Wenger; S Fujibayashi; M Donoviel; F Esch; F Hill; J S O'Brien
Journal:  Biochem Biophys Res Commun       Date:  1986-01-29       Impact factor: 3.575

8.  A variant form of metachromatic leukodystrophy without arylsulfatase deficiency.

Authors:  A F Hahn; B A Gordon; G G Hinton; J J Gilbert
Journal:  Ann Neurol       Date:  1982-07       Impact factor: 10.422

9.  Metachromatic leukodystrophy without arylsulfatase A deficiency.

Authors:  L J Shapiro; K A Aleck; M M Kaback; H Itabashi; R J Desnick; N Brand; R L Stevens; A L Fluharty; H Kihara
Journal:  Pediatr Res       Date:  1979-10       Impact factor: 3.756

10.  A protein activator of galactosylceramide beta-galactosidase.

Authors:  D A Wenger; M Sattler; S Roth
Journal:  Biochim Biophys Acta       Date:  1982-09-14
View more
  3 in total

1.  Sphingolipid activator protein 1 deficiency in metachromatic leucodystrophy with normal arylsulphatase A activity. A clinical, morphological, biochemical, and immunological study.

Authors:  W Schlote; K Harzer; H Christomanou; B C Paton; B Kustermann-Kuhn; B Schmid; J Seeger; U Beudt; I Schuster; U Langenbeck
Journal:  Eur J Pediatr       Date:  1991-06       Impact factor: 3.183

2.  Additional biochemical findings in a patient and fetal sibling with a genetic defect in the sphingolipid activator protein (SAP) precursor, prosaposin. Evidence for a deficiency in SAP-1 and for a normal lysosomal neuraminidase.

Authors:  B C Paton; B Schmid; B Kustermann-Kuhn; A Poulos; K Harzer
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

3.  Sphingolipid activator proteins in a human hereditary renal disease with deposition of disialogangliosides.

Authors:  A Haltia; M L Solin; H Jalanko; C Holmberg; A Miettinen; H Holthöfer
Journal:  Histochem J       Date:  1996-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.